FindTrial
Sign In

Development of Beam Imaging Technology for Scanning Irradiation in Heavy Ion Radiotherapy

Development of Beam Imaging Technology for Scanning Irradiation in Heavy Ion Radiotherapy - Development of Beam Imaging Technology for Scanning Irradiation in Heavy Ion Radiotherapy

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000062039
Enrollment
5
Registered
2026-06-24
Start date
2026-06-24
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choroidal malignant melanoma.

Interventions

None listed

Sponsors

National Institutes for Quantum Science and Technology (QST)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients aged 18 years or older with choroidal malignant melanoma who are scheduled to undergo heavy ion radiotherapy, and from whom informed consent has been obtained.

Exclusion criteria

Exclusion criteria: Individuals deemed unsuitable for participation in this study by the principal investigator or other responsible physicians due to medical or other reasons.

Design outcomes

Primary

MeasureTime frame
Measurement of Irradiation Field in Patients with Choroidal Malignant Melanoma Using a Secondary Electron Bremsstrahlung (SEB) Imaging System—

Secondary

MeasureTime frame
Estimation of Treatment Beam Range Based on Two-Dimensional Measurement of Irradiation Energy and Secondary Electron Bremsstrahlung—

Countries

Japan

Contacts

Public ContactMasaru Wakatsuki

National Institutes for Quantum Science and Technology (QST) QST Hospital

wakatsuki.masaru@qst.go.jp043-206-3360

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026